Endocannabinoids / edited by Loren Parsons, Matthew Hill.

Format:

Book

Contributor:

Parsons, Loren, editor.

Hill, Matthew, 1980- editor.

Series:

International review of neurobiology ; v. 125.

International review of neurobiology, 0074-7742 ; volume one hundred and twenty-five

Language:

English

Subjects (All):

Cannabinoids.

Cannabinoids--Receptors.

Cannabinoids--Physiological effect.

Physical Description:

1 online resource (368 p.)

Edition:

First edition.

Place of Publication:

Amsterdam : Elsevier Science, 2015.

Summary:

Endocannabinoids , the latest volume in the International Review of Neurobiology series is a comprehensive overview of the state-of-the-art research into the neurobiology of migraines. It reviews the current knowledge and understanding in the field, and provides a starting point for researchers and practitioners entering the field. Contains the expertise of contributors in the field of the neurobiology of migraines The endocannabinoid system is the biological system in the body which mediates the effects of cannabis Provides an up to date, comprehensive overview of the biological functions of endocannabinoid signaling in the brain and how it regulates an array of processes, such as brain development, reward, emotion and pain

Contents:

Front Cover; Endocannabinoids; Copyright; Contents; Contributors; Preface; Chapter One: The Endocannabinoid Signaling System in the CNS: A Primer; 1. Introduction; 2. The Endocannabinoids; 2.1. Definitions; 2.2. Mechanisms of AEA Biosynthesis; 2.2.1. Precursor Synthesis; 2.2.2. NAPE Conversion to NAE: NAPE-PLD; 2.2.3. NAPE Conversion to NAE: Multienzyme Pathways; 2.2.4. AEA Synthesis from AA; 2.2.5. Summary; 2.3. Mechanisms of AEA Hydrolysis; 2.3.1. Fatty Acid Amide Hydrolase; 2.3.2. NAE-Hydrolyzing Acid Amidase: A Peripheral AEA Hydrolase; 2.4. Mechanisms of 2-AG Biosynthesis

2.4.1. Diacylglycerol Lipase2.4.2. Mechanisms of DAG Synthesis; 2.5. Mechanisms of 2-AG Catabolism; 2.5.1. Monoacylglycerol Lipase; 2.5.2. Other Enzymes that Hydrolyze 2-AG in the Brain; 2.5.3. Contribution of 2-AG to AA Concentrations; 2.6. Other Inactivation Mechanisms for AEA and 2-AG; 2.6.1. Uptake, Accumulation, and Sequestration; 2.6.2. Oxygenation of the Arachidonate Backbone; 3. Endocannabinoid Receptors; 3.1. Introduction; 3.2. CB1 Cannabinoid Receptors; 3.2.1. CB1R Signaling; 3.2.2. CB1R Pharmacology; 4. CB1R and Retrograde Regulation of Synaptic Activity; 4.1. The Basic Paradigms

4.1.1. Short-Term Depression of Synaptic Transmission4.1.2. Long-Term Depression of Transmission; 5. Summary; Acknowledgments; References; Chapter Two: Evidence for a Role of Adolescent Endocannabinoid Signaling in Regulating HPA Axis Stress Responsivity and E ...; 1. Adolescence and Pubertal Maturation; 2. The Neurobiology of Stress; 3. Adolescent HPA Axis Development; 4. The Developmental Influence of Gonadal Hormones on the HPA Axis; 5. The Endocannabinoid System; 6. Endocannabinoid System Regulation of the HPA Axis in Adulthood; 7. Ontogeny of the Endocannabinoid System

8. Adolescent HPA Axis Function: A Regulatory Role for the Endocannabinoid System?8.1. Adolescent Stress Exposure Modulates Corticolimbic Endocannabinoid Signaling; 8.2. Adolescent Cannabinoid Exposure Modifies Adult Stress-Induced HPA Axis Activity; 8.3. Long-Term Consequences of Adolescent Endocannabinoid System Dysregulation on the Developing Brain and Behavior; 9. Concluding Remarks; Acknowledgments; References; Chapter Three: The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestin...; 1. Introduction

2. The Enteric Nervous System and the Brain-Gut Axis2.1. The Structure of the ENS; 3. The Endocannabinoid System; 3.1. Cannabinoid Receptors and Their Ligands; 3.2. Cannabinoid Receptors in the ENS; 3.3. Endocannabinoid Synthesis; 3.4. 2-AG Synthesis and Degradation; 3.5. Anandamide Synthesis and Degradation; 4. Endocannabinoid Signaling Mechanisms; 4.1. Endocannabinoid Transport Mechanisms; 5. Other Receptors, Agonists, and Antagonists; 5.1. Phytocannabinoids; 5.2. Peptide Endocannabinoids; 5.3. Transient Receptor Potential Vanilloid 1; 5.4. Virodhamine, an Endogenous CB1 Antagonist

5.5. G Protein-Coupled Receptor 55

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

Description based on online resource; title from PDF title page (ebrary, viewed December 31, 2015).

ISBN:

0-12-801278-1

0-12-801376-1

OCLC:

932337741